Peptides.
Understand
Before You Ask.

A peptide is a short chain of amino acids — the same building blocks the body uses to make proteins. Where proteins are typically long chains of fifty or more amino acids folded into complex structures, peptides are shorter, usually somewhere between two and fifty amino acids linked together.

The human body makes and uses thousands of peptides naturally. Insulin, which regulates blood sugar, is a peptide hormone. Oxytocin and glucagon are peptides. So are many of the signalling molecules involved in skin repair, digestion, appetite, and immune response. In this sense, peptides are not a novel or foreign category of substance — they are part of ordinary human biochemistry.

Peptides generally act as signalling molecules. Rather than doing physical work themselves, most peptides bind to specific receptors on the surface of cells and instruct those cells to start, stop, or adjust a particular process — for example, releasing a hormone, initiating repair, or regulating inflammation.

Because each peptide's amino acid sequence determines which receptors it binds to, peptides can be highly specific compared with many other classes of molecule. This specificity is also why small changes to a peptide's structure, dose, or purity can meaningfully change how it behaves in the body — and why peptide medicines require careful formulation, accurate dosing, and clinical oversight rather than casual or unsupervised use.

• Peptide medicines can have significant physiological effects, including on hormone levels, metabolism, and immune function.
• Purity, sterility, and dosing accuracy materially affect safety — which is why lawful compounding occurs only in certified sterile facilities with batch testing.
• Appropriate use depends on individual health history, which only a registered medical practitioner is qualified to assess.
• Products sold outside the prescription system — including many "research chemical" or grey-market peptides marketed online — are not required to meet any purity, sterility, or labelling standard, and carry real safety and legal risk.

For all of these reasons, New Zealand law treats peptide medicines the same way it treats other prescription medicines: a registered medical practitioner must assess whether a genuine clinical need exists before one can be prescribed. That assessment is a clinical decision, not a formality, and it is not something this website performs.